Deodorizing preparations containing nanosacle chitosans and/or chitosan derivatives

• US 6,916,465 B2
• Filed: 03/14/2001
• Issued: 07/12/2005
• Est. Priority Date: 03/23/2000
• Status: Expired due to Fees

• Current Assignee: Cognis International GmbH (BASF SE)
• Original Assignee: Cognis Deutschland GmbH & Co. KG (BASF SE)
• Inventors: Panzer, Claudia, Wachter, Rolf
• Primary Examiner(s): Dodson, Shelley A.
• Application Number:
  US10/239,553
• Publication Number:
  US 20030133891A1
• Time in Patent Office: 1,581 Days
• Field of Search: 424/65, 424/69, 424/400, 424/401
• US Class Current: 424/65
• CPC Class Codes: A61K 2800/413 Nanosized, i.e. having sizes below 100 nm
• CPC Class Codes: A61K 8/0241 Containing particulates characterized by their shape and/or structure see also A61K8/04, A61K8/11, and A61K8/14, further aspects are classified in A61K2800/40 and subcodes
• CPC Class Codes: A61K 8/736 Chitin; Chitosan; Derivatives thereof
• CPC Class Codes: A61Q 15/00 Anti-perspirants or body deodorants deodorisation of air A61L9/00
• CPC Class Codes: B82Y 5/00 Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Abstract

A deodorizing composition containing an ingredient selected from the group consisting of a nanoscale chitosan having a particle diameter of from about 1 to 300 nm, a nanoscale chitosan derivative having a particle diameter of from about 1 to 300 nm, and mixtures thereof.

Claims

1. A deodorizing composition comprising a particulate ingredient selected from the group consisting of nanoscale chitosan having an average particle size range of from about 1 to 300 nm, nanoscale chitosan derivatives having an average particle size range of from about 1 to 300 nm, and mixtures thereof, wherein the particulate ingredient is prepared by a process which comprises:

(a) dissolving the chitosan or chitosan derivative starting material in a solvent for the material to form a fluid mixture at supercritical or near supercritical conditions;

(b) expanding the fluid mixture into a vacuum, a gas or a liquid while simultaneously evaporating the solvent to form the particles.

2. The composition of claim 1 wherein the particulate has an average particle size range of from about 10 to 200 nm.

3. The composition of claim 1 wherein the particulate ingredient has an average particle size range of from about 50 to 150 nm.

4. The composition of claim 1 wherein the particulate ingredient has a molecular weight of from about 50,000 to 2,000,000.

5. The composition of claim 1 wherein the nanoscale chitosan derivative comprises a member selected from the group consisting of anionically derivatized chitosan, nonionically derivatized chitosan, cationically derivatized chitosan, and mixtures thereof.

6. The composition of claim 1 wherein the particulate ingredient is present in the composition in an amount of from about 0.01 to 5% by weight, based on the weight of the composition.

7. The composition of claim 1 wherein the particulate ingredient is present in the composition in an amount of from about 0.1 to 1% by weight, based on the weight of the composition.

8. The composition of claim 1 wherein the particulate ingredient is present in the composition in an amount of from about 0.2 to 0.6% by weight, based on the weight of the composition.

9. The composition of claim 1 further comprising an auxiliary ingredient selected from the group consisting of an esterase inhibitor, a bactericidal agent, a bacteriostatic agent, an oil component, an antiperspirant, a perspiration absorber, and mixtures thereof.

19. The composition of claim 1 wherein the fluid mixture is expanded into a liquid containing a protecting colloid.

20. The composition of claim 1 wherein the liquid comprises water.

10. A process for inhibiting body odor formation comprising contacting human skin with a deodorizing composition containing a particulate ingredient selected from the group consisting of a nanoscale chitosan having an average particle size range of from about 1 to 300 nm, nanoscale chitosan derivatives having an average particle size range of from about 1 to 300 nm, and mixtures thereof, wherein the particulate ingredient is prepared by a process which comprises:

(a) dissolving the chitosan or chitosan derivative starting material in a solvent for the material to form a fluid mixture at supercritical or near supercritical conditions;

(b) expanding the fluid mixture into a vacuum, a gas or a liquid while simultaneously evaporating the solvent to form the particles.

11. The process of claim 10 wherein the particulate ingredient has an average particle size range of from about 10 to 200 nm.

12. The process of claim 10 wherein the particulate ingredient has an average particle size range of from about 50 to 150 nm.

13. The process of claim 10 wherein the particulate ingredient has a molecular weight of from about 50,000 to 2,000,000.

14. The process of claim 10 wherein the nanoscale chitosan derivative comprises a member selected from the group consisting of anionically derivatized chitosan, nonionically derivatized chitosan, cationically derivatized chitosan, and mixtures thereof.

15. The process of claim 10 where the particulate ingredient is present in the composition in an amount of from about 0.1 to 5% by weight, based on the weight of the composition.

16. The process of claim 10 wherein the particulate ingredient is present in the composition in an amount of from about 0.1 to 1% by weight, based on the weight of the composition.

17. The process of claim 10 wherein the particulate ingredient is present in the composition in an amount of from about 0.2 to 0.6% by weight, based on the weight of the composition.

18. The process of claim 10 further comprising an auxiliary ingredient selected from the group consisting of esterase inhibitors, bactericidal agents, bacteriostatic agents, oil components, antiperspirants, perspiration absorbers, and mixtures thereof.